12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Diane 35 cyproterone/ethinylestradiol regulatory update

France's National Agency for the Safety of Medicines and Health Products (ANSM) announced it would suspend approval of Bayer's Diane 35 cyproterone/ethinylestradiol and its generic versions within 3 months following a review of data. EMA said ANSM considered the drugs are associated with...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >